Drug abuse

As per available reports about 1510 journals, 45 Conferences, 35 workshops are presently dedicated exclusively to Drug Abuse and about 4470550 articles are being published on the current trends in Drug Abuse.  In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Drug abuse are being carried out. Drug abuse is a major health and social problem that may be associated with morbidity and mortality. It is considered by many societies as an antisocial or even criminal behavior. Susceptibility to addiction is multifactorial with complex genetic basis characterized by phenotypic and genetic heterogeneity. Candidate genes are those concerned with action and metabolism of abused drug or those that encode neurotransmitter systems. Comorbidity means the concomitance or sequential development of two disorders in one cohort. High prevalence of comorbidities does not mean that one condition caused the other, even if one appeared first. Neurocardiac involvement may be in the form of the heart’s effects on the brain as in embolic stroke as a sequel of cardiac disease, the brain’s effects on the heart as in neurogenic heart disease, and neurocardiac syndromes like Friedreich's ataxia. Recently, increasing evidences suggest genetic and epigenetic factors as a cause of comorbidity. Single nucleotide polymorphisms (SNPs) is the most interesting risk factor that could explain the personal variation in disease susceptibility especially the multifactorial comorbid disorders. In this article, we will review the role SNPs as a risk factor for the comorbidity of drug abuse and ischemic heart disease.

The Journal of Gene Technology is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in genetic pre disposition. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Gene Technology provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of genetic testing, susceptibility and pre disposition thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences (5th Cell and Gene Therapy Conference May 19-21, 2016, San Antonio, USA Cell and Gene Therapy Conference is to ameliorate the knowledge, awareness, and education on cell and gene therapy leading to the discovery of genetic and cellular therapies which aid to alleviate the human disease as it is the most significant emerging technology in the eyes of Medical, Biotechnology, Pharmaceuticals and Academia. Cell and Gene Therapy Conference 2016 is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists).